Enrolling by invitationPhase 2NCT05285878
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Studying Complication after organ transplantation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Methodist Hospital Research Institute
- Intervention
- Fingolimod(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2022 – 2027
Study locations (1)
- Houston Methodist Research Institute, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05285878 on ClinicalTrials.govOther trials for Complication after organ transplantation
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06872333Allo HSCT for High Risk HemoglobinopathiesMasonic Cancer Center, University of Minnesota
- RECRUITINGNANCT06512519Second Haplo-transplantation for Graft FailurePeking University People's Hospital
- RECRUITINGNANCT06512545Modified Second Haplo-transplantation for Graft FailurePeking University People's Hospital
- RECRUITINGNCT05836922Association Between Renal Regional Oxygen Saturation Measured by Near-InfraRed Spectroscopy and Postoperative Renal Failure After Lung Transplantation Surgery: A Pilot StudyAssistance Publique Hopitaux De Marseille
- RECRUITINGNANCT06386198HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant RecipientsUniversity of California, San Francisco
- RECRUITINGEARLY PHASE1NCT04469842Early Use of Long-acting Tacrolimus in Lung Transplant RecipientsVanderbilt University Medical Center
- ENROLLING BY INVITATIONNCT05818644Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in ChildrenUniversity Medical Center Groningen
- ACTIVE NOT RECRUITINGPHASE4NCT05557370Immunogenicity of HPV Vaccine in Transplant Recipients.Medical College of Wisconsin
See all trials for Complication after organ transplantation →